Last reviewed · How we verify
Zirconium Zr 89-Df-Crefmirlimab — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Zirconium Zr 89-Df-Crefmirlimab (Zirconium Zr 89-Df-Crefmirlimab) — City of Hope Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Zirconium Zr 89-Df-Crefmirlimab TARGET | Zirconium Zr 89-Df-Crefmirlimab | City of Hope Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Zirconium Zr 89-Df-Crefmirlimab CI watch — RSS
- Zirconium Zr 89-Df-Crefmirlimab CI watch — Atom
- Zirconium Zr 89-Df-Crefmirlimab CI watch — JSON
- Zirconium Zr 89-Df-Crefmirlimab alone — RSS
Cite this brief
Drug Landscape (2026). Zirconium Zr 89-Df-Crefmirlimab — Competitive Intelligence Brief. https://druglandscape.com/ci/zirconium-zr-89-df-crefmirlimab. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab